UM
Residential Collegefalse
Status已發表Published
Identification of a novel HLA-A2-restrictive CTL epitope of an ovary cancer-associated antigen OVA66
Jin S.; Wang Y.; Wang S.J.; Zhang H.Z.; Li M.X.; Chen Y.; Ge H.L.
2005-03-01
Source PublicationXi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology
ISSN10078738
Volume21Issue:2
AbstractAIM: To identify a novel HLA-A2-restrictive CTL epitope of an ovary cancer-associated antigen OVA66. METHODS: Dendritic cells (DCs), induced from peripheral blood mononuclear cells(PBMCs) by cytokines, were confirmed by morphological observation and FACS. Mature DCs were pulsed with each of the two synthesized peptides which were selected as possible CTL epitopes by software analysis. The pulsed DCs were used to stimulate autologous CD8+ T cells from an HLA-A2+ healthy donor. One week later, the peptides-pulsed autologous PBMCs were used to stimulate the CD8+ T cells for another 3 times at weekly intervals. The stimulated CD8+ T cells were used as CTLs. The cytotoxicity of CTLs to target cells was detected by lactate dehydrogenase (LDH) release assay and the number of T cells secreting antigen-specific IFN-gamma in CTLs was analyzed by enzyme-linked immunospot assay (ELISPOT). RESULTS: The results of morphology observation and FACS indicated that mature DCs were induced from PBMCs. Of the two peptides, peptide L235(FLPDHINIV) induced peptide-specific CD8+ T cells that lysed HLA-A2+ T2 cells pulsed with L235 and OVA66+/HLA-A2+ SW480 cells. Compared with control peptide, L235 increased the number of IFN-gamma producing T cells. CONCLUSION: This novel OVA66-derived CTL epitope L235 can induce HLA-A2-restrictive CTL response, which lays the foundation for preparation of tumor-specific peptide vaccine.
URLView the original
Language英語English
Fulltext Access
Document TypeJournal article
CollectionUniversity of Macau
AffiliationShanghai Second Medical University
Recommended Citation
GB/T 7714
Jin S.,Wang Y.,Wang S.J.,et al. Identification of a novel HLA-A2-restrictive CTL epitope of an ovary cancer-associated antigen OVA66[J]. Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology, 2005, 21(2).
APA Jin S.., Wang Y.., Wang S.J.., Zhang H.Z.., Li M.X.., Chen Y.., & Ge H.L. (2005). Identification of a novel HLA-A2-restrictive CTL epitope of an ovary cancer-associated antigen OVA66. Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology, 21(2).
MLA Jin S.,et al."Identification of a novel HLA-A2-restrictive CTL epitope of an ovary cancer-associated antigen OVA66".Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology 21.2(2005).
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Jin S.]'s Articles
[Wang Y.]'s Articles
[Wang S.J.]'s Articles
Baidu academic
Similar articles in Baidu academic
[Jin S.]'s Articles
[Wang Y.]'s Articles
[Wang S.J.]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Jin S.]'s Articles
[Wang Y.]'s Articles
[Wang S.J.]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.